• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $WRBY

    Warby Parker Inc.

    Subscribe to $WRBY
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

    IPO Year: 2021

    Exchange: NYSE

    Website: warbyparker.com

    Recent Analyst Ratings for Warby Parker Inc.

    DatePrice TargetRatingAnalyst
    6/29/2026$33.00Buy
    BofA Securities
    5/8/2026$32.00 → $33.00Outperform
    Telsey Advisory Group
    12/10/2025$30.00Mkt Perform → Mkt Outperform
    Citizens JMP
    11/7/2025$28.00 → $24.00Outperform
    Telsey Advisory Group
    8/1/2025$22.00 → $28.00Outperform
    Telsey Advisory Group
    7/10/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    4/30/2025$17.00Sell → Neutral
    Citigroup
    4/17/2025$27.00Hold → Buy
    Loop Capital
    2/28/2025$28.00 → $30.00Outperform
    Telsey Advisory Group
    2/25/2025$26.00Neutral
    ROTH MKM
    See more ratings

    Warby Parker Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities initiated coverage on Warby Parker with a new price target

    BofA Securities initiated coverage of Warby Parker with a rating of Buy and set a new price target of $33.00

    6/29/26 9:34:50 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

    Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $33.00 from $32.00 previously

    5/8/26 8:14:41 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Warby Parker from Mkt Perform to Mkt Outperform and set a new price target of $30.00

    12/10/25 9:45:30 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

    Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $24.00 from $28.00 previously

    11/7/25 7:48:31 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

    Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $28.00 from $22.00 previously

    8/1/25 8:16:04 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker downgraded by Citizens JMP

    Citizens JMP downgraded Warby Parker from Mkt Outperform to Mkt Perform

    7/10/25 8:37:20 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker upgraded by Citigroup with a new price target

    Citigroup upgraded Warby Parker from Sell to Neutral and set a new price target of $17.00

    4/30/25 1:18:55 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker upgraded by Loop Capital with a new price target

    Loop Capital upgraded Warby Parker from Hold to Buy and set a new price target of $27.00

    4/17/25 8:27:42 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

    Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $30.00 from $28.00 previously

    2/28/25 8:48:26 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    ROTH MKM initiated coverage on Warby Parker with a new price target

    ROTH MKM initiated coverage of Warby Parker with a rating of Neutral and set a new price target of $26.00

    2/25/25 7:15:06 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Blumenthal Neil Harris converted options into 9,200 shares and sold $275,908 worth of shares (9,200 units at $29.99) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    7/8/26 9:17:19 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Co-Chief Executive Officer Gilboa David Abraham converted options into 54,347 shares and sold $1,621,714 worth of shares (54,347 units at $29.84) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    7/8/26 9:15:09 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Co-Chief Executive Officer Blumenthal Neil Harris converted options into 189,320 shares and sold $6,445,120 worth of shares (217,667 units at $29.61) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    7/2/26 8:16:06 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Co-Chief Executive Officer Gilboa David Abraham converted options into 213,746 shares and sold $7,191,541 worth of shares (242,221 units at $29.69) as part of a pre-agreed trading plan, decreasing direct ownership by 48% to 31,112 units (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    7/2/26 8:14:02 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Director Raider Jeffrey Jacob sold $668,700 worth of shares (22,500 units at $29.72) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 435,201 units (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    7/2/26 8:10:09 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Co-Chief Executive Officer Blumenthal Neil Harris converted options into 36,300 shares and sold $1,090,452 worth of shares (36,300 units at $30.04) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    7/1/26 6:46:20 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form 4 filed by Co-Chief Executive Officer Blumenthal Neil Harris

    4 - Warby Parker Inc. (0001504776) (Issuer)

    6/23/26 4:48:06 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Director Briggs Teresa sold $129,683 worth of shares (5,000 units at $25.94) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 48,883 units (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    6/18/26 5:39:27 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Director Moon Youngme E sold $265,300 worth of shares (10,000 units at $26.53), decreasing direct ownership by 28% to 26,061 units (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    6/12/26 5:13:17 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Director Williams Ronald A was granted 13,006 shares, increasing direct ownership by 13% to 113,629 units (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    6/10/26 4:58:32 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Singer Bradley E bought $965,750 worth of shares (75,000 units at $12.88) (SEC Form 4)

    4 - Warby Parker Inc. (0001504776) (Issuer)

    8/14/24 4:52:02 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. Press Releases

    Fastest customizable press release news feed in the world

    View All

    Warby Parker to Announce Second Quarter 2026 Financial Results on August 6, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the second quarter ended June 30, 2026, will be released before market open on August 6, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing (833) 461-5787 from the U.S. or (585) 542-9983 from international locations. The conference passcode is 317476957. A live webcast of the conference call will be available on the investors section of the Company’s website at investors.warbyparker.com where

    7/16/26 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 22, 2026, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from S&P MidCap 400 and S&P SmallCap 600 are no longer representative of the mid-cap and small-cap market space, respectively.  Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorJune 22, 2026

    6/5/26 7:25:00 PM ET
    $BLKB
    $BRBR
    $CABO
    Computer Software: Prepackaged Software
    Technology
    Packaged Foods
    Consumer Staples

    Warby Parker Announces Participation in Upcoming 2026 Baird Global Consumer, Technology & Services Conference

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a lifestyle brand focused on vision for all, today announced that the Company will be presenting at the 2026 Baird Global Consumer, Technology & Services Conference on Tuesday, June 2, 2026 at 12:50 pm Eastern Time. The presentation will be webcast live over the internet and can be accessed at https://investors.warbyparker.com/. An online archive will be available for a period of 90 days following the presentation. About Warby Parker Warby Parker (NYSE:WRBY) was founded in 2010 with a mission to inspire and impact the world with vision, purpose, and style–without charging a premium for it. Headquartered in New York City, the co-founder-led li

    5/28/26 8:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Unveils First Intelligent Eyewear Design

    Rooted in the brand's signature aesthetic, debut style balances elevated design with effortless, all-day wear Warby Parker Inc. (NYSE:WRBY), a lifestyle brand focused on vision for all, today unveiled its first Intelligent Eyewear frame designed for all-day, everyday wear. The debut style combines Warby Parker's distinctive approach to design with Google's leadership in AI and Samsung's mobile leadership to create beautifully crafted eyewear that seamlessly enhances everyday life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260519092381/en/ For more than 16 years, Warby Parker has redefined how consumers shop for glasses by

    5/19/26 1:45:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Announces First Quarter 2026 Results

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2026. Highlights Delivered revenue growth of 8.3%, exceeding the Company's guidance. Drove Active Customer growth of 4.8% to 2.69 million on a trailing 12-month basis, and Average Revenue per Customer of $331, up 6.9% year over year. Generated net income of $3.2 million, and expanded Adjusted EBITDA(1) to $29.6 million, exceeding the Company's guidance. Delivered operating cash flow of $24.5 million and Free Cash Flow(1) of $8.4 million, ending the quarter with $288.2 million in

    5/7/26 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Launches Warby Parker Sport, Expanding into the Performance Eyewear Category

    The new collection brings together technical performance and signature style, designed to move with you—on the course, on the run, and everywhere in between. Warby Parker Inc. (NYSE:WRBY), a lifestyle brand focused on vision for all, announced the launch of Warby Parker Sport, a new category of performance eyewear. As the brand's most advanced performance offering, this collection seamlessly bridges the gap between everyday style and sport-specific functionality. "We've never believed performance and great design have to be trade-offs. Our goal with Warby Parker Sport was to make approachable performance eyewear that transitions seamlessly from everyday wear to active moments," said Dav

    4/28/26 8:30:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce First Quarter 2026 Financial Results on May 7, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2026, will be released before market open on May 7, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing (833) 461-5787 from the U.S. or (585) 542-9983 from international locations. The conference passcode is 508282561. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where pr

    4/16/26 4:05:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Announces Fourth Quarter and Full Year 2025 Results

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights Delivered revenue growth of 13.0% for full year 2025 and 11.2% for the fourth quarter. Drove Active Customer growth of 7.0%, and Average Revenue per Customer of $324, up 5.7% year over year. Achieved first full year of positive net income of $1.6 million, and expanded Adjusted EBITDA(1) by 30.2% year over year to $95.2 million and Adjusted EBITDA Margin(1) by 140 basis points to 10.9%. Delivered third consecutive year of positive operating cash

    2/26/26 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2025 will be released before market open on February 26, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 275034. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

    2/12/26 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Appoints Adrian Mitchell as Chief Financial Officer

    Warby Parker Inc. (NYSE:WRBY), a direct-to-consumer lifestyle brand focused on vision for all, today announced the appointment of Adrian Mitchell as Chief Financial Officer, effective February 10, 2026. His appointment strengthens Warby Parker's leadership team as the company continues executing its strategic vision, building on a track record of retail and product innovation while expanding into new categories, including the launch of its first AI glasses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209259218/en/Adrian Mitchell, Chief Financial Officer Mitchell has more than 25 years of experience leading some of the worl

    2/9/26 4:10:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. SEC Filings

    View All

    SEC Form 144 filed by Warby Parker Inc.

    144 - Warby Parker Inc. (0001504776) (Subject)

    7/6/26 4:26:55 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Warby Parker Inc. (0001504776) (Filer)

    6/12/26 4:53:48 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form 144 filed by Warby Parker Inc.

    144 - Warby Parker Inc. (0001504776) (Subject)

    6/12/26 4:00:13 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Warby Parker Inc.

    SCHEDULE 13G/A - Warby Parker Inc. (0001504776) (Subject)

    6/4/26 1:21:37 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form 144 filed by Warby Parker Inc.

    144 - Warby Parker Inc. (0001504776) (Subject)

    5/13/26 5:40:30 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form 10-Q filed by Warby Parker Inc.

    10-Q - Warby Parker Inc. (0001504776) (Filer)

    5/7/26 4:44:21 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Warby Parker Inc. (0001504776) (Filer)

    5/7/26 6:48:08 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form DEFA14A filed by Warby Parker Inc.

    DEFA14A - Warby Parker Inc. (0001504776) (Filer)

    4/28/26 4:50:48 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form DEF 14A filed by Warby Parker Inc.

    DEF 14A - Warby Parker Inc. (0001504776) (Filer)

    4/28/26 4:46:12 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form 144 filed by Warby Parker Inc.

    144 - Warby Parker Inc. (0001504776) (Subject)

    4/16/26 4:12:34 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/14/24 5:08:23 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/14/24 1:30:16 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    11/12/24 10:40:28 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    9/10/24 10:30:07 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    7/10/24 4:30:10 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    6/7/24 10:14:20 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    5/10/24 10:03:20 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    2/14/24 10:04:37 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    2/13/24 5:17:30 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    SEC Form SC 13G/A filed by Warby Parker Inc. (Amendment)

    SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

    2/13/24 4:56:25 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. Leadership Updates

    Live Leadership Updates

    View All

    Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 22, 2026, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from S&P MidCap 400 and S&P SmallCap 600 are no longer representative of the mid-cap and small-cap market space, respectively.  Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorJune 22, 2026

    6/5/26 7:25:00 PM ET
    $BLKB
    $BRBR
    $CABO
    Computer Software: Prepackaged Software
    Technology
    Packaged Foods
    Consumer Staples

    Warby Parker Appoints Adrian Mitchell as Chief Financial Officer

    Warby Parker Inc. (NYSE:WRBY), a direct-to-consumer lifestyle brand focused on vision for all, today announced the appointment of Adrian Mitchell as Chief Financial Officer, effective February 10, 2026. His appointment strengthens Warby Parker's leadership team as the company continues executing its strategic vision, building on a track record of retail and product innovation while expanding into new categories, including the launch of its first AI glasses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209259218/en/Adrian Mitchell, Chief Financial Officer Mitchell has more than 25 years of experience leading some of the worl

    2/9/26 4:10:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Monumental Sports & Entertainment Appoints Corporate Finance Executive Steven Miller as Executive Vice President and Chief Financial Officer

    Steven Miller, currently Chief Financial Officer and Treasurer of Warby Parker (NYSE: WRBY), has been appointed Chief Financial Officer of Monumental Sports & Entertainment, effective October 2, 2025, and will join the Senior Executive Leadership TeamAs previously announced, after an extraordinary 25-year career at Monumental Sports & Entertainment, Peter Biché transitioned from Chief Financial Officer to Senior Advisor WASHINGTON, Sept. 9, 2025 /PRNewswire/ -- Monumental Sports & Entertainment (MSE), one of the nation's leading integrated sports, media, and entertainment companies, announced that Steven (Steve) Miller will become its Executive Vice President and Chief Financial Officer (CFO

    9/9/25 6:30:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company") announced today the appointment of Ron Williams as Lead Director. "Ron's deep expertise in transformational leadership is helping Warby Parker lead the way in making the optical industry more customer and patient friendly. Our shareholders and our team are lucky to have such an exceptional and experienced leader as our first Lead Director," said Neil Blumenthal, co-Founder and co-CEO. The Company has also appointed a new independent director, Brad Singer, to its board of directors. Mr. Singer's appointment is effective today, August 1, 2024. "Brad brings a wealth of experience as a dynamic operator and investor," said Dav

    8/1/24 4:15:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Inc. Financials

    Live finance-specific insights

    View All

    Warby Parker to Announce Second Quarter 2026 Financial Results on August 6, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the second quarter ended June 30, 2026, will be released before market open on August 6, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing (833) 461-5787 from the U.S. or (585) 542-9983 from international locations. The conference passcode is 317476957. A live webcast of the conference call will be available on the investors section of the Company’s website at investors.warbyparker.com where

    7/16/26 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Announces First Quarter 2026 Results

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2026. Highlights Delivered revenue growth of 8.3%, exceeding the Company's guidance. Drove Active Customer growth of 4.8% to 2.69 million on a trailing 12-month basis, and Average Revenue per Customer of $331, up 6.9% year over year. Generated net income of $3.2 million, and expanded Adjusted EBITDA(1) to $29.6 million, exceeding the Company's guidance. Delivered operating cash flow of $24.5 million and Free Cash Flow(1) of $8.4 million, ending the quarter with $288.2 million in

    5/7/26 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce First Quarter 2026 Financial Results on May 7, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2026, will be released before market open on May 7, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing (833) 461-5787 from the U.S. or (585) 542-9983 from international locations. The conference passcode is 508282561. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where pr

    4/16/26 4:05:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Announces Fourth Quarter and Full Year 2025 Results

    Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights Delivered revenue growth of 13.0% for full year 2025 and 11.2% for the fourth quarter. Drove Active Customer growth of 7.0%, and Average Revenue per Customer of $324, up 5.7% year over year. Achieved first full year of positive net income of $1.6 million, and expanded Adjusted EBITDA(1) by 30.2% year over year to $95.2 million and Adjusted EBITDA Margin(1) by 140 basis points to 10.9%. Delivered third consecutive year of positive operating cash

    2/26/26 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2025 will be released before market open on February 26, 2026. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 275034. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.c

    2/12/26 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Announces Third Quarter 2025 Results

    Net revenue growth accelerated to 15% year over year Active Customers growth accelerated to 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2025. "This was a strong quarter for our team as we advanced our strategic priorities and accelerated both topline and customer growth. As we step into Warby Parker's next act, one defined by innovation through AI, we're energized to create new products like AI glasses, enhance the customer experience and drive productivity," shared Co-Founder and Co-CEO Neil Blume

    11/6/25 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2025 will be released before market open on November 6, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 646-844-6383 from international locations. The conference passcode is 958403. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where p

    10/16/25 7:00:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Announces Second Quarter 2025 Results

    Net revenue increased 14% year over year to $214 million; Raises outlook Active Customers increased 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the second quarter ended June 30, 2025. "It has been a busy and exciting year marked by major milestones. We celebrated opening our 300th store and distributing 20 million pairs of glasses to people in need around the world. Looking ahead, our partnership with Google to develop intelligent eyewear is a testament to Warby Parker's commitment to innovation as we shape the future of how people

    8/7/25 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker to Announce Second Quarter 2025 Financial Results August 7, 2025

    Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the second quarter ended June 30, 2025 will be released before market open on August 7, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 754099. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where present

    7/17/25 4:05:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Warby Parker Announces First Quarter 2025 Results

    Net revenue increased 12% year over year to $224 million Active Customers increased 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2025. "Our team delivered a strong start to 2025. We opened 11 net new stores, exceeded profitability expectations, drove the highest e-commerce growth we've seen since 2021, and delivered our seventh consecutive quarter of accelerating active customer growth," shared Co-Founder and Co-CEO Neil Blumenthal. "Looking to the rest of the year, we'll leverage our diversified suppl

    5/8/25 6:45:00 AM ET
    $WRBY
    Ophthalmic Goods
    Health Care